Animal models of acute exacerbation of pulmonary fibrosis

X Ye, M Zhang, H Gu, M Liu, Y Zhao, Y Shi, S Wu… - Respiratory …, 2023 - Springer
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive scarring interstitial lung disease
with an unknown cause. Some patients may experience acute exacerbations (AE), which …

Mechanisms underlying dose-limiting toxicities of conventional chemotherapeutic agents

MA Manavi, MH Fathian Nasab… - Journal of …, 2023 - Taylor & Francis
Dose-limiting toxicities (DLTs) are severe adverse effects that define the maximum tolerated
dose of a cancer drug. In addition to the specific mechanisms of each drug, common …

[引用][C] 间充质干细胞及细胞外囊泡治疗肺纤维化的现状与未来

王艳阳, 刘婵, 余丽梅, 何志旭 - 中国组织工程研究, 2024

[引用][C] Current status and future of treatment of pulmonary fibrosis by mesenchymal stem cells and extracellular vesicles

Y Wang, C Liu, L Yu, Z He - Chinese Journal of Tissue Engineering Research, 2024